Literature DB >> 8914896

Antifungal activity against allergic fungal sinusitis organisms.

J P Bent1, F A Kuhn.   

Abstract

A review of more than 50 allergic fungal sinusitis (AFS) patients indicates that most patients experience postoperative recurrences once weaned from oral steroids, leaving a glaring need for improved treatment. Topical antifungal therapy has not been described for AFS, but it could potentially lower fungal antigen loads via postoperative irrigations. No information exists to direct the choice of antifungal agent. The purpose of this study was to identify the appropriate drug to use for postoperative irrigations in AFS patients. Twenty-two fungal cultures grown from 15 AFS patients were studied for in vitro susceptibility to five common antifungal drugs: ketoconazole, amphotericin B, itraconazole, nystatin, and fluconazole. Results demonstrated that ketoconazole and amphotericin B were the most effective. Clinical trials are indicated to evaluate the efficacy of these drugs as a supplement to current AFS treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8914896     DOI: 10.1097/00005537-199611000-00005

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  13 in total

Review 1.  Severe rhinosinusitis.

Authors:  Rosemary Hallett; Stanley M Naguwa
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

2.  The mold conundrum in chronic hyperplastic sinusitis.

Authors:  Fenna A Ebbens; Christos Georgalas; Wytske J Fokkens
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

3.  Mycotic keratitis due to Curvularia senegalensis and in vitro antifungal susceptibilities of Curvularia spp.

Authors:  J Guarro; T Akiti; R A Horta; L A Morizot Leite-Filho; J Gené; S Ferreira-Gomes; C Aguilar; M Ortoneda
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

4.  Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B.

Authors:  S Frankenburg; D Glick; S Klaus; Y Barenholz
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

5.  Allergic Aspergillus flavus rhinosinusitis: a case report from Qatar.

Authors:  Saad J Taj-Aldeen; Ali A Hilal; Agustin Chong-Lopez
Journal:  Eur Arch Otorhinolaryngol       Date:  2002-12-20       Impact factor: 2.503

6.  Rate of allergic fungal etiology of chronic rhinosinusitis in Turkish population.

Authors:  Yusuf Hidir; Fuat Tosun; Mehmet Ali Saracli; Armagan Gunal; Mustafa Gulec; Sertac Yetiser
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-10       Impact factor: 2.503

Review 7.  The mold conundrum in chronic rhinosinusitis: where do we stand today?

Authors:  Fenna A Ebbens; Wytske J Fokkens
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

Review 8.  Allergic fungal sinusitis: pathogenesis and management strategies.

Authors:  Mark S Schubert
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Immunotherapy in allergic fungal sinusitis: The controversy continues. A recent review of literature.

Authors:  Mary S Doellman; Gregory R Dion; Erik Kent Weitzel; Erika Gonzalez Reyes
Journal:  Allergy Rhinol (Providence)       Date:  2013

Review 10.  Fungal rhinosinusitis: diagnosis and therapy.

Authors:  M S Schubert
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.